79 Percent of Healthcare Leaders See ROI in Clinical Surveillance; Four in Five Say It Definitely Improves Quality Measures

Sage Growth Partners (SGP) recently announced survey findings on how clinical surveillance is prioritized and managed by healthcare delivery organizations. The survey of healthcare executives from hospitals across the U.S. was commissioned by VigiLanz, a clinical surveillance company, to assess their progress in the journey to higher value care and how they are using data analytics, EMRs and clinical surveillance tools to support their efforts.

The full report is available here. Key findings include:

Majority are using a clinical surveillance solution and see it as important to their organization

EMRs aren’t meeting all hospitals’ clinical surveillance and data analytics needs

The return on investment (ROI) for clinical surveillance is clear

Link between hospital revenue and value-based care is strong going into 2019

“As hospitals continue to take on more value-based payment models, their ROI for clinical surveillance will grow,” said David Goldsteen, MD, CEO of VigiLanz. “At the same time, our survey showed that those who use a third-party solution for clinical surveillance are also more involved in value-based payment models, suggesting that they view clinical surveillance is a key lever for their success. I believe that we will only continue to see hospital leaders and physicians choose these solutions for a broader spectrum of patient care insights than is available through EMRs. These insights lead to more optimal care decisions that help them meet quality and cost targets and will lead to greater success under value-based payment models now and in the future.”

Write a Comment

Your email address will not be published. Required fields are marked *